Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

563 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rationale and Design of a Randomized, Open-Label, Parallel-Group Study of Esaxerenone Versus Angiotensin Receptor Blockers in Older Patients With Uncontrolled Hypertension on Calcium Channel Blocker Monotherapy (ESCORT-HT).
Kario K, Katsuya T, Shimosawa T, Taguchi T, Tanabe A, Ohishi M; ESCORT‐HT investigators. Kario K, et al. Among authors: tanabe a. J Clin Hypertens (Greenwich). 2024 Nov 25. doi: 10.1111/jch.14947. Online ahead of print. J Clin Hypertens (Greenwich). 2024. PMID: 39584450 Free article.
Predictor of Steroid Replacement Duration after Removal of Cortisol-producing Adenoma.
Kubo Y, Sone M, Katabami T, Izawa S, Ichijo T, Tsuiki M, Okamura S, Yoshimoto T, Otsuki M, Takeda Y, Suzuki T, Naruse M, Tanabe A; ACPA-J Study Group. Kubo Y, et al. Among authors: tanabe a. Intern Med. 2024 Oct 18. doi: 10.2169/internalmedicine.4339-24. Online ahead of print. Intern Med. 2024. PMID: 39428528 Free article.
Differences in target organ damage between captopril challenge test-defined definitive-positive and borderline-range groups among patients with primary aldosteronism.
Fujiwara N, Haze T, Wakui H, Tamura K, Tsuiki M, Kamemura K, Taura D, Ichijo T, Takahashi Y, Watanabe M, Kobayashi H, Nakamura T, Izawa S, Wada N, Yamada T, Yokota K, Naruse M, Sone M; JPAS II study group. Fujiwara N, et al. Hypertens Res. 2024 Oct 15. doi: 10.1038/s41440-024-01943-w. Online ahead of print. Hypertens Res. 2024. PMID: 39402300
Home blood pressure-lowering effect of esaxerenone versus trichlormethiazide for uncontrolled hypertension: a predefined subanalysis of the EXCITE-HT randomized controlled trial by basal calcium channel blocker versus angiotensin receptor blocker.
Kario K, Ohbayashi H, Hashimoto M, Itabashi N, Kato M, Uchiyama K, Hirano K, Nakamura N, Miyamoto T, Nagashima H, Ishida H, Ebe Y, Hatta T, Fukui T, Shimosawa T, Katsuya T, Taguchi T, Tanabe A, Ohishi M; EXCITE-HT investigators. Kario K, et al. Among authors: tanabe a. Hypertens Res. 2024 Oct 12. doi: 10.1038/s41440-024-01887-1. Online ahead of print. Hypertens Res. 2024. PMID: 39394512
563 results